宫腔粘连TCRA术后常规治疗联合仿生物电刺激预防宫腔再次粘连的临床效果
2019-02-11邓金梅冷颖伍敏
邓金梅 冷颖 伍敏



[摘要]目的 分析宮腔镜宫腔粘连分离术(TCRA)治疗宫腔粘连后,以常规药物治疗联合仿生物电刺激技术预防宫腔再次粘连的临床价值。方法 选取2018年1月~2019年6月在我院接受TCRA治疗的56例宫腔粘连确诊患者作为研究对象,按照随机数字表法,将其分为对照组(28例)和治疗组(28例)。对照组患者采用TCRA+宫腔内放置透明质酸钠凝胶2 ml及注水4.5~5.0 ml Floy导管+大剂量雌激素孕激素人工周期治疗。治疗组在上述治疗基础上联合仿生物电刺激进行治疗。比较两组患者的宫腔再次粘连事件发生情况、手术治疗总有效率、治疗前后子宫内膜厚度、妊娠结局和月经情况。结果 治疗组患者的宫腔粘连复发率低于对照组,差异有统计学意义(P<0.05);治疗组患者的妊娠率高于对照组,差异有统计学意义(P<0.05);治疗组患者的手术总有效率高于对照组,差异有统计学意义(P<0.05);两组患者治疗后的月经量多于治疗前,月经周期短于治疗前,行经时间长于治疗前,差异有统计学意义(P<0.05);治疗后,治疗组患者的月经量多于对照组,月经周期、行经时间长于对照组,差异有统计学意义(P<0.05);两组患者治疗后的子宫内膜厚度均高于治疗前,差异有统计学意义(P<0.05);治疗后,治疗组患者的子宫内膜厚度高于对照组,差异有统计学意义(P<0.05)。结论 宫腔粘连患者在TCRA术后采用常规药物联合仿生物电刺激技术进行治疗,可以预防宫腔再次粘连事件的发生,大幅度改善子宫内膜厚度,缩短术后治疗时间,提高妊娠率,使治疗的总有效率得到显著提升。
[关键词]宫腔粘连;宫腔镜;手术;常规药物;仿生物电刺激;宫腔再次粘连;预防
[中图分类号] R656.705 [文献标识码] A [文章编号] 1674-4721(2019)12(b)-0059-04
Clinical effect of conventional treatment combined with biomimetic electrical stimulation on preventing the recurrence of intrauterine adhesion after TCRA surgery
DENG Jin-mei LENG Ying WU Min
Department of Obstetrics and Gynecology, Yichun Maternal and Child Health Care Hospital, Jiangxi Province, Yichun 336000, China
[Abstract] Objective To analyze the clinical value of conventional drugs treatment combined with biomimetic electrical stimulation in the prevention of intrauterine adhesions after hysteroscopic intrauterine adhesion separation (TCRA) surgery. Methods From January 2018 to June 2019, 56 patients diagnosed with intrauterine adhesions who were treated by TCRA in our hospital were selected as the study objects. The patients were divided into control group (28 cases) and treatment group (28 cases) according to the random number table method. The control group was treated with TCRA combined with intrauterine adhesions and intrauterine injection of Sodium Hyaluronate Gel 2 ml and 4.5-5 ml Floy catheter plus high-dose estrogen progesterone cycle therapy. The treatment group was treated with a combination of biomimetic electrical stimulation on the basis of the above treatment. The occurrence of intrauterine readhesion, total effective rate of surgical treatment, the endometrial thickness before and after treatment, pregnancy outcome and menstrual status were compared between the two groups. Results The recurrence rate of intrauterine adhesions in the treatment group was lower than that in the control group, the difference was statistically significant (P<0.05). The pregnancy rate in the treatment group was higher than that in the control group, and the difference was statistically significant (P<0.05). The total effective rate of surgical treatment of the patients in the treatment group was higher than that in the control group, and the difference was statistically significant (P<0.05). The menstrual volume after treatment of patients in both groups were higher than before treatment, the menstrual cycle of patients in both groups were shorter than before treatment, and the menstrual period of patients in both groups were longer than before treatment, the differences were statistically significant (P<0.05). After treatment, the menstrual volume of patients in the treatment group was higher than that in the control group, the menstrual cycle and menstrual duration were longer than those in the control group, and the differences were statistically significant (P<0.05). The endometrial thickness of the two groups after treatment were higher than those before treatment, and the differences were statistically significant (P<0.05). After treatment, endometrial thickness in the treatment group was higher than that in the control group, with statistically significant difference (P<0.05). Conclusion After TCRA surgery, the patients with intrauterine adhesions treated with conventional drugs and biomimetic electrical stimulation can prevent the occurrence of intrauterine adhesions, significantly improve the thickness of endometrium, shorten the postoperative treatment time, improve the pregnancy rate, and significantly improve the total effective rate of treatment.
[Key words] Uterine cavity adhesion; Hysteroscopy; Surgery; Conventional drugs; Biologic electrical stimulation; Uterine cavity adhesion again; Prevention
宫腔粘连属于一种综合征类疾病[1],是一种由于各种因素影响导致的子宫内膜基底层受到损伤、子宫肌壁发生相互粘连,并因此对子宫腔的生理解剖结构造成破坏,使子宫腔或宫颈出现部分或完全粘连所引起的疾病。月经量减少是宫腔粘连患者的主要特征表现,病情程度严重者,甚至还会出现月经点滴状或闭经、周期性下腹疼痛、流产、继发性不孕等情况,严重影响患者的身心健康,因此有必要探讨行之有效的方式治疗宫腔粘连[2]。随着医学技术的进步和发展,仿生物电刺激治疗宫腔粘连患者成为了可行方案,在实际应用中可通过刺激血管平滑肌的收缩,加速组织修复和生理功能恢复,有效促进患者的子宫内膜生长,增加子宫内膜厚度[3]。……
